SCANCELL HOLDINGS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.875 GBX | +1.80% |
|
+7.92% | -5.95% |
| 03-26 | Scancell doses first patient in melanoma-focused trials | AN |
| 03-22 | Seneca Growth Capital announces tepid 2023 results | AN |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 10.50 | 11.25 | 12.00 |
| Spread/Res. | -5.95% | -12.22% | -17.71% |
| Spread/Supp. | +10.71% | +10.71% | +7.92% |
| Support | 8.920 | 8.920 | 9.150 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- SCLP Stock
- Charts Scancell Holdings plc